Oral cyclophosphamide-induced posterior reversible encephalopathy syndrome in a patient with ANCA-associated vasculitis: A case report

BACKGROUND: Posterior reversible encephalopathy syndrome (PRES) manifests many neurological symptoms with typical features on neuroimaging studies and has various risk factors. Cyclophosphamide is one of the therapeutic agents for anti-neutrophil cytoplasmic antibody (ANCA)-associated vasculitis. Cy...

Descripción completa

Detalles Bibliográficos
Autores principales: Kim, Yire, Kwak, Jihye, Jung, Sehyun, Lee, Seunghye, Jang, Ha Nee, Cho, Hyun Seop, Chang, Se-Ho, Kim, Hyun-Jung
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Baishideng Publishing Group Inc 2021
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8316926/
https://www.ncbi.nlm.nih.gov/pubmed/34368335
http://dx.doi.org/10.12998/wjcc.v9.i21.6130

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8316926/
https://www.ncbi.nlm.nih.gov/pubmed/34368335
http://dx.doi.org/10.12998/wjcc.v9.i21.6130

Ejemplares similares